High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$618K
$618,375
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
PTCT
S
PTC THERAPEUTICS, INC.
Boulding Mark Elliott
• Officer • EXEC. VP AND CLO
10b5-1 Sell
2026-02-19
$209,763x4
|
||||||
| PTCT |
PTC THERAPEUTICS, INC.
|
Officer • EXEC. VP AND CLO
10b5-1 Sell
|
2026-02-19 | $209,763x4 | S | Form 4 |
|
PTCT
S
PTC THERAPEUTICS, INC.
Boulding Mark Elliott
• Officer • EXEC. VP AND CLO
Sell to Cover
2026-02-18
$213,698
|
||||||
| PTCT |
PTC THERAPEUTICS, INC.
|
Officer • EXEC. VP AND CLO
Sell to Cover
|
2026-02-18 | $213,698 | S | Form 4 |
|
PTCT
M
PTC THERAPEUTICS, INC.
Boulding Mark Elliott
• Officer • EXEC. VP AND CLO
Other
2026-02-17
$72,266
|
||||||
| PTCT |
PTC THERAPEUTICS, INC.
|
Officer • EXEC. VP AND CLO
Other
|
2026-02-17 | $72,266 | M | Form 4 |
|
PTCT
S
PTC THERAPEUTICS, INC.
Boulding Mark Elliott
• Officer • EXEC. VP AND CLO
10b5-1 Sell
2026-02-17
$194,914x2
|
||||||
| PTCT |
PTC THERAPEUTICS, INC.
|
Officer • EXEC. VP AND CLO
10b5-1 Sell
|
2026-02-17 | $194,914x2 | S | Form 4 |